Business Description
Aelis Farma SA
ISIN : FR0014007ZB4
Compare
Compare
Traded in other countries / regions
AELIS.France69O.Germany IPO Date
2022-02-21Description
Aelis Farma SA is a biotechnology Company specializing in the research and development of treatment's related to brain diseases.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.48 | |||||
| Equity-to-Asset | 0.49 | |||||
| Debt-to-Equity | 0.51 | |||||
| Debt-to-EBITDA | -0.79 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 1.66 | |||||
| Beneish M-Score | -0.09 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -5.8 | |||||
| 3-Year EPS without NRI Growth Rate | -22.4 | |||||
| 3-Year FCF Growth Rate | -56.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 22.95 | |||||
| 9-Day RSI | 23.21 | |||||
| 14-Day RSI | 24.89 | |||||
| 6-1 Month Momentum % | -77.46 | |||||
| 12-1 Month Momentum % | -78.57 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.97 | |||||
| Quick Ratio | 2.97 | |||||
| Cash Ratio | 1.99 | |||||
| Days Sales Outstanding | 79.22 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -11.2 | |||||
| Shareholder Yield % | -1.87 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -101.75 | |||||
| Net Margin % | -93.06 | |||||
| FCF Margin % | -175.66 | |||||
| ROE % | -52.39 | |||||
| ROA % | -26.15 | |||||
| ROIC % | -105.54 | |||||
| ROC (Joel Greenblatt) % | -436.72 | |||||
| ROCE % | -40.3 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 0.7 | |||||
| PS Ratio | 3.5 | |||||
| PB Ratio | 2.65 | |||||
| Price-to-Tangible-Book | 2.69 | |||||
| EV-to-EBIT | -2.89 | |||||
| EV-to-EBITDA | -3.07 | |||||
| EV-to-Revenue | 2.61 | |||||
| EV-to-FCF | -1.49 | |||||
| Price-to-Net-Current-Asset-Value | 3.21 | |||||
| Price-to-Net-Cash | 12.63 | |||||
| Earnings Yield (Greenblatt) % | -34.6 | |||||
| FCF Yield % | -48.71 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Aelis Farma SA Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 7.552 | ||
| EPS (TTM) (€) | -0.532 | ||
| Beta | 0 | ||
| Volatility % | 62.05 | ||
| 14-Day RSI | 24.89 | ||
| 14-Day ATR (€) | 0.068885 | ||
| 20-Day SMA (€) | 2.38 | ||
| 12-1 Month Momentum % | -78.57 | ||
| 52-Week Range (€) | 2.02 - 13.45 | ||
| Shares Outstanding (Mil) | 13.62 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Aelis Farma SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Aelis Farma SA Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Aelis Farma SA Frequently Asked Questions
What is Aelis Farma SA(FRA:69O)'s stock price today?
The current price of FRA:69O is €2.02. The 52 week high of FRA:69O is €13.45 and 52 week low is €2.02.
When is next earnings date of Aelis Farma SA(FRA:69O)?
The next earnings date of Aelis Farma SA(FRA:69O) is .
Does Aelis Farma SA(FRA:69O) pay dividends? If so, how much?
Aelis Farma SA(FRA:69O) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers